Qualcomm to Increase Chip Prices by Double-Digit Percentage Starting September 1
In BlockBeats news on July 30, during the Qualcomm earnings conference call, CEO Amon revealed that Qualcomm plans to increase product prices starting from September 1, with the increase reaching double digits, in order to drive profitability back to historical levels. He stated that the price hike is driven by the rising costs across the entire supply chain, not just the impact of memory chip price increases. Amon said the company will conduct pricing negotiations with each customer individually, stating that "the temporary slight decline in gross margin is due to the phased misalignment of cost and pricing."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
